A new method developed using data from the M.D. Anderson Cancer Center found that a haemoglobin level of <12g/dL, total circulating lymphocyte count of >2.5 x 109/L, >0% immature myeloid cells, >10% bone marrow blasts causes a reduced overall survival.
A novel method, utilizing data from the M.D. Anderson Cancer Center, discovered that a haemoglobin level below 12g/dL, a total circulating lymphocyte count above 2.5 x 10^9/L, more than 0% immature myeloid cells, and over 10% bone marrow blasts are associated with decreased overall survival.